Onyx Biotec Key Ratios
NSE: ONYX
₹36.00
₹0.00 (0.00%)As on 04-Nov-2026 09:08IST
Market cap
₹65 Cr
Revenue (TTM)
₹69 Cr
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 12.13 | 20.73 | -- |
| EBIT | -- | -- | -95.14 | -50.85 | -- |
| Net Profit | -- | -- | -104.33 | -148.80 | -- |
| EPS | -- | -- | -104.33 | -142.29 | -- |
| Book Value | -- | -- | -0.39 | 25.60 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 8.16 | -- | 0.51 | 11.83 | 12.13 |
| Net Margin
| 4.76 | -- | -0.31 | 7.85 | 6.75 |
| Return on equity
| 9.52 | -- | -0.39 | 12.25 | 16.71 |
| Return on Capital
| 9.23 | -- | 1.15 | 13.68 | 12.85 |
| Return on Assets
| 3.74 | -- | -0.23 | 5.99 | 5.47 |
| Debt to Equity (x)
| -- | -- | 0.27 | 0.22 | 1.22 |
Profitability
ROCE
1.15
Lower than Peers by 10.06
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
1.15
|
13.68
|
12.85
|
8.21
|
15.52
|
|
Peer Median
|
11.21
|
12.19
|
11.06
|
9.85
|
--
|
ROE
-0.39
Lower than Peers by 8.55
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
-0.39
|
12.25
|
16.71
|
10.67
|
20.47
|
|
Peer Median
|
8.16
|
9.26
|
7.17
|
7.54
|
--
|
ROA
-0.23
Lower than Peers by 4.94
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
-0.23
|
5.99
|
5.47
|
3.86
|
9.10
|
|
Peer Median
|
4.71
|
7.65
|
3.78
|
3.99
|
--
|
EBIT Margin
0.51
Lower than Peers by 20.86
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
0.51
|
11.83
|
12.13
|
7.59
|
9.64
|
|
Peer Median
|
21.37
|
--
|
12.49
|
13.66
|
--
|
Net Margin
-0.31
Lower than Peers by 4.10
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
-0.31
|
7.85
|
6.75
|
4.66
|
7.45
|
|
Peer Median
|
3.79
|
5.63
|
2.96
|
2.70
|
--
|
Cash Profit Margin
4.08
Higher than Peers by 4.08
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
4.08
|
12.92
|
10.24
|
8.45
|
10.70
|
|
Peer Median
|
0.00
|
--
|
0.00
|
0.00
|
--
|
Revenue Growth
12.13
Lower than Peers by 40.72
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
12.13
|
15.27
|
36.14
|
-11.99
|
--
|
|
Peer Median
|
52.85
|
--
|
39.85
|
38.90
|
--
|
EBIT Growth
-95.14
Lower than Peers by 308.71
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
-95.14
|
12.37
|
117.62
|
-30.69
|
--
|
|
Peer Median
|
213.56
|
--
|
20.42
|
176.64
|
--
|
Net Profit Growth
-104.33
Lower than Peers by 314.39
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
-104.33
|
36.31
|
97.04
|
-44.98
|
--
|
|
Peer Median
|
210.06
|
--
|
12.85
|
218.06
|
--
|
EPS Growth
-104.33
Lower than Peers by 307.10
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
-104.33
|
0.15
|
74.57
|
-44.98
|
--
|
|
Peer Median
|
202.77
|
--
|
33.33
|
200.00
|
--
|
Book Value Growth
-0.39
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
-0.39
|
119.96
|
38.93
|
11.15
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.27
Higher than Peers by 0.09
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
0.27
|
0.22
|
1.22
|
1.61
|
0.75
|
|
Peer Median
|
0.19
|
0.22
|
0.20
|
0.19
|
--
|
Short term debt to equity ratio
0.16
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
0.16
|
0.07
|
0.12
|
0.40
|
0.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.58
Lower than Peers by 0.82
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
1.58
|
1.91
|
1.31
|
0.72
|
1.44
|
|
Peer Median
|
2.39
|
1.99
|
2.03
|
1.95
|
--
|
Quick Ratio
1.15
Lower than Peers by 3.66
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
1.15
|
1.29
|
0.91
|
0.42
|
1.17
|
|
Peer Median
|
4.81
|
--
|
1.12
|
1.24
|
--
|
Interest Coverage
0.66
Lower than Peers by 2.84
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
0.66
|
4.21
|
3.08
|
5.43
|
6.86
|
|
Peer Median
|
3.50
|
4.14
|
2.98
|
3.48
|
--
|
Operating Efficiency
Debtors to sales
39.58
Lower than Peers by 10.61
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
39.58
|
32.66
|
28.60
|
12.86
|
18.76
|
|
Peer Median
|
50.20
|
--
|
29.85
|
41.06
|
--
|
Asset Turnover
0.75
Lower than Peers by 2.19
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
0.75
|
0.75
|
0.81
|
0.83
|
1.22
|
|
Peer Median
|
2.93
|
--
|
1.55
|
3.06
|
--
|
Receivable days
125.39
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
125.39
|
104.88
|
69.43
|
62.37
|
68.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
79.18
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
79.18
|
74.24
|
52.40
|
43.36
|
24.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
121.46
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
121.46
|
142.32
|
105.74
|
97.57
|
59.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
83.11
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
83.11
|
36.80
|
16.09
|
8.16
|
33.92
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
--
|
21.23
|
--
|
--
|
--
|
|
Peer Median
|
33.08
|
44.20
|
39.23
|
34.42
|
--
|
Price / Book Value
1.11
Lower than Peers by 0.85
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
1.11
|
1.89
|
--
|
--
|
--
|
|
Peer Median
|
1.96
|
2.96
|
2.56
|
2.03
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
18.89
Higher than Peers by 2.07
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
18.89
|
9.45
|
5.01
|
7.61
|
3.08
|
|
Peer Median
|
16.82
|
23.15
|
24.73
|
22.79
|
--
|
Market Cap
62
Higher than Peers by 20
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Onyx Biotec
|
62
|
105
|
--
|
--
|
--
|
|
Peer Median
|
41
|
55
|
58
|
40
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
